Characterization of antimalarial activity of artemisinin-based hybrid drugs
Antimicrobial Agents and Chemotherapy · 2024
DOI: 10.1128/aac.00143-24 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antimicrobial Agents and Chemotherapy, 2024. Verfasst von Helenita Costa Quadros und 11 weiteren Autor:innen. Beteiligte Einrichtung: Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil. Hauptthemen laut MEDLINE: Artemisinins, Antimalarials, Plasmodium falciparum. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deutsche Forschungsgemeinschaft (DFG), Bayerisches Staatsministerium für Bildung und Kultus, Wissenschaft und Kunst (Bavarian State Ministry of Education, Science and the Arts), Fondation pour la Recherche Médicale (FRM).
Abstract (Originalsprache)
In response to the spread of artemisinin (ART) resistance, ART-based hybrid drugs were developed, and their activity profile was characterized against drug-sensitive and drug-resistant Plasmodium falciparum parasites. Two hybrids were found to display parasite growth reduction, stage-specificity, speed of activity, additivity of activity in drug combinations, and stability in hepatic microsomes of similar levels to those displayed by dihydroartemisinin (DHA). Conversely, the rate of chemical homolysis of the peroxide bonds is slower in hybrids than in DHA. From a mechanistic perspective, heme plays a central role in the chemical homolysis of peroxide, inhibiting heme detoxification and disrupting parasite heme redox homeostasis. The hybrid exhibiting slow homolysis of peroxide bonds was more potent in reducing the viability of ART-resistant parasites in a ring-stage survival assay than the hybrid exhibiting fast homolysis. However, both hybrids showed limited activity against ART-induced quiescent parasites in the quiescent-stage survival assay. Our findings are consistent with previous results showing that slow homolysis of peroxide-containing drugs may retain activity against proliferating ART-resistant parasites. However, our data suggest that this property does not overcome the limited activity of peroxides in killing non-proliferating parasites in a quiescent state.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Instituto Gonçalo Moniz, Fundação Oswaldo Cruz (FIOCRUZ), Salvador, Brazil.
- Organic Chemistry Chair I and Interdisciplinary Center for Molecular Materials (ICMM), Friedrich-Alexander-Universität of Erlangen-Nürnberg, Erlangen, Germany.
- LCC-CNRS, Laboratoire de Chimie de Coordination, Université de Toulouse, CNRS, Toulouse, France.
- MAAP, New Antimalarial Molecules and Pharmacological Approaches, Inserm ERL 1289, Toulouse, France.
- Institut de Pharmacologie et de Biologie Structurale (IPBS), Université de Toulouse, CNRS, Université Toulouse III - Paul Sabatier (UPS), Toulouse, France.
- Drug Discovery and Development Centre (H3D), Department of Chemistry, University of Cape Town, Rondebosch, South Africa.
ORCID-Profile: Helenita Costa Quadros, Lucie Paloque, Mariana C Borges-Silva, Godwin Akpeko Dziwornu, Sarah D'Alessandro, Kelly Chibale, Nicoletta Basilico, Françoise Benoit-Vical, Svetlana B Tsogoeva, Diogo Rodrigo M Moreira
Förderung
- Deutsche Forschungsgemeinschaft (DFG)
- Bayerisches Staatsministerium für Bildung und Kultus, Wissenschaft und Kunst (Bavarian State Ministry of Education, Science and the Arts)
- Fondation pour la Recherche Médicale (FRM)
- Centre National de la Recherche Scientifique (CNRS)
- Institut National de la Santé et de la Recherche Médicale (Inserm)
- Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq)
- Fundação Oswaldo Cruz (FIOCRUZ)
- Ministero degli Affari Esteri e della Cooperazione Internazionale (MAECI)
Zitieren
APA
Quadros, H. C., Herrmann, L., Manaranche, J., Paloque, L., Borges-Silva, M. C., Dziwornu, G. A., D'Alessandro, S., Chibale, K., Basilico, N., Benoit-Vical, F., Tsogoeva, S. B., & Moreira, D. R. M. (2024). Characterization of antimalarial activity of artemisinin-based hybrid drugs. Antimicrobial Agents and Chemotherapy. https://doi.org/10.1128/aac.00143-24
Vancouver
Quadros HC, Herrmann L, Manaranche J, Paloque L, Borges-Silva MC, Dziwornu GA, et al. Characterization of antimalarial activity of artemisinin-based hybrid drugs. Antimicrobial Agents and Chemotherapy. 2024. doi:10.1128/aac.00143-24
BibTeX
@article{Quadros2024,
author = {Quadros, Helenita Costa and Herrmann, Lars and Manaranche, Jeanne and Paloque, Lucie and Borges-Silva, Mariana C and Dziwornu, Godwin Akpeko and D'Alessandro, Sarah and Chibale, Kelly and Basilico, Nicoletta and Benoit-Vical, Françoise and Tsogoeva, Svetlana B and Moreira, Diogo Rodrigo M},
title = {Characterization of antimalarial activity of artemisinin-based hybrid drugs},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2024},
doi = {10.1128/aac.00143-24}
}
EUVIMED